Skip to main content
Clinical Trials/NCT04427371
NCT04427371
Unknown
Not Applicable

Zhongda Hospital, School of Medicine, Southeast University

Jianfeng Xie1 site in 1 country100 target enrollmentMay 22, 2020
ConditionsSepsis

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Sepsis
Sponsor
Jianfeng Xie
Enrollment
100
Locations
1
Primary Endpoint
28-day mortality
Last Updated
5 years ago

Overview

Brief Summary

Sepsis is a life-threatening disease characterized by multi-organ failure due to dysregulated host response to infection, with high global mortality of 30-50%. One of the most important pathophysiologic hallmarks in sepsis is vascular endothelial injury that contributes to the severity and outcome of the syndrome. Effective treatments for endothelial cell injury in sepsis have been lacking to improve prognosis. Endothelial pyroptosis is a vital mechanism of vascular endothelial injury in sepsis; mitigation or abolishment of endothelial cell pyroptosis alleviate vascular endothelial damage and improve the prognosis of sepsis mice. Gasdermin D (GSDMD) mediated endothelial pyroptosis plays a critical role in modulating vascular endothelial injury in sepsis.

Long non-coding RNA (lncRNA), as a class of non-coding protein RNA longer than 200 kD, contributes to a variety of cell biological processes. The dysregulation of lncRNA results in the occurrence and development of tumors, diabetes, sepsis and other diseases. Therefore, we detected lncRNA and mRNA expression profile in 26 blood samples of septic patients using Arraystar LncRNA Microarray. We found lncRNA NBR2 regulates septic endothelial pyroptosis.

To assess any correlation of pyroptosis levels with relevant endothelial cell injury parameters and determine the prognostic value in septic patients. we measured the levels of pyroptosis in patients admitted to the Department of Critical Care Medicine for sepsis and investigated the correlation with related markers of endothelium injury. Furthermore, we determined the prognostic value of pyroptosis levels for the mortality of patients with sepsis.

Detailed Description

We measured the levels of pyroptosis in patients admitted to the Department of Critical Care Medicine for sepsis and investigated the correlation with related markers of endothelium injury. Furthermore, we determined the prognostic value of pyroptosis levels for the mortality of patients with sepsis.

Registry
clinicaltrials.gov
Start Date
May 22, 2020
End Date
December 31, 2023
Last Updated
5 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Jianfeng Xie
Responsible Party
Sponsor Investigator
Principal Investigator

Jianfeng Xie

Dr.

Southeast University, China

Eligibility Criteria

Inclusion Criteria

  • Suspected or confirmed infection
  • The sequential organ failure score (SOFA score) increases by more than or equal to 2 points on the basis
  • Sign the informed consent

Exclusion Criteria

  • the age \< 18 or \> 80 years of age
  • viral hepatitis or liver cirrhosis
  • chronic renal tubular nephritis, chronic renal insufficiency
  • ulcerative colitis or crohn's disease
  • active systemic lupus erythematosus (SLE)
  • acute myocardial infarction
  • acute pancreatitis
  • engaged in other clinical subjects

Outcomes

Primary Outcomes

28-day mortality

Time Frame: 28-day

all-cause 28-day mortality

Study Sites (1)

Loading locations...

Similar Trials